CTNM
Contineum Therapeutics Inc.
$11.63
-$1.44(-11.02%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$340.56M
Volume
1.50M
52W Range
$3.35 - $15.25
Target Price
$22.00
Company Overview
| Mkt Cap | $340.56M | Price | $11.63 |
| Volume | 1.50M | Change | -11.02% |
| P/E Ratio | -8.1 | Open | $12.33 |
| Revenue | -- | Prev Close | $13.07 |
| Net Income | $-42.3M | 52W Range | $3.35 - $15.25 |
| Div Yield | N/A | Target | $22.00 |
| Overall | 54 | Value | 60 |
| Quality | 39 | Technical | 63 |
No chart data available
Latest News
Contineum Therapeutics Submits Phase 2 Trial for PIPE-791
TipRanks Auto-Generated Newsdesk•2 days ago
Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from RBC Capital
TipRanks Auto-Generated Intelligence Newsdesk•23 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.63 | -11.0% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW